State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
Identification
Number)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17CFR
240.13e-4(c))
|
Item
2.02
|
Results
of Operations and Financial
Condition
|
Item
9.01
|
Financial
Statements and
Exhibits
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
Release dated March 5, 2008Announcing Results for Fourth Quarter and
Year Ended December 31,
2007
|
ACURA PHARMACEUTICALS, INC. | ||
|
|
|
By: | /s/ Peter A. Clemens | |
Peter A. Clemens |
||
Senior Vice President & Chief Financial Officer |
Exhibit
Number
|
Description
|
|
99.1
|
Press
Release dated March 5, 2008Announcing Results for Fourth Quarter and
Year Ended December 31, 2007
|